GO
Loading...

Eli Lilly and Co

More

  • Midday Glance: Pharmaceuticals companies Thursday, 21 Aug 2014 | 1:22 PM ET

    Baxter International Inc. rose$. 71 or. 9 percent, to $75.96. Bristol-Myers Squibb Co. fell$. 13 or. 2 percent, to $49.92. Hospira fell$. 12 or. 2 percent, to $54.79.

  • Aug 21- An experimental new psoriasis treatment from Eli Lilly and Co proved superior to Amgen Inc's blockbuster Enbrel, drawing it closer to a potential marketing battle with new products being developed by Amgen and Novartis AG.

  • Lilly psoriasis drug fares well in late-stage test Thursday, 21 Aug 2014 | 8:55 AM ET

    INDIANAPOLIS— Drugmaker Eli Lilly and Co. said its potential psoriasis treatment fared better than both a fake drug and a competitor's product during late-stage testing on patients with the most common form of the skin disease.

  • Aug 21- Eli Lilly and Co said its experimental psoriasis drug was found to be more effective in clearing skin than a generic treatment and a placebo in late-stage studies. The most common inflammatory disease in the United States- it can occur on any part of the body- it is associated with diabetes and heart disease.

  • Lilly psoriasis drug succeeds in late-stage studies Thursday, 21 Aug 2014 | 7:16 AM ET

    Aug 21- Eli Lilly and Co said its experimental psoriasis drug was found to be more effective in clearing skin than a generic treatment and a placebo in late-stage studies. Three studies evaluated the drug, ixekizumab, against the generic etanercept and a placebo, in patients with moderate-to-severe plaque psoriasis.

  • Final Glance: Pharmaceuticals companies Wednesday, 20 Aug 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 12 or. 2 percent, to $75.25. Bristol-Myers Squibb Co. fell$. 26 or. 5 percent, to $50.04. Hospira rose$. 99 or 1.8 percent, to $54.91.

  • Midday Glance: Pharmaceuticals companies Wednesday, 20 Aug 2014 | 1:49 PM ET

    Baxter International Inc. rose$. 11 or. 1 percent, to $75.24. Bristol-Myers Squibb Co. fell$. 18 or. 4 percent, to $50.12. Hospira rose$. 70 or 1.3 percent, to $54.62.

  • Early Glance: Pharmaceuticals companies Wednesday, 20 Aug 2014 | 12:21 PM ET

    Baxter International Inc. fell$. 35 or. 5 percent, to $74.78. Bristol-Myers Squibb Co. fell$. 16 or. 3 percent, to $50.14. Hospira rose$. 45 or. 8 percent, to $54.37.

  • Final Glance: Pharmaceuticals companies Tuesday, 19 Aug 2014 | 6:09 PM ET

    Baxter International Inc. fell$. 08 or. 1 percent, to $75.13. Bristol-Myers Squibb Co. rose$. 31 or. 6 percent, to $50.30. Hospira fell $1.56 or 2.8 percent, to $53.92.

  • Midday Glance: Pharmaceuticals companies Tuesday, 19 Aug 2014 | 4:03 PM ET

    Baxter International Inc. rose$. 01 or percent, to $75.22. Bristol-Myers Squibb Co. fell$. 15 or. 3 percent, to $49.84. Hospira fell $1.18 or 2.1 percent, to $54.30.

  • Final Glance: Pharmaceuticals companies Monday, 18 Aug 2014 | 6:02 PM ET

    Baxter International Inc. rose$. 80 or 1.1 percent, to $75.21. Bristol-Myers Squibb Co. rose$. 31 or. 6 percent, to $49.99. Hospira rose$. 46 or. 8 percent, to $55.48.

  • Early Glance: Pharmaceuticals companies Monday, 18 Aug 2014 | 10:29 AM ET

    Baxter International Inc. rose$. 81 or 1.1 percent, to $75.22. Bristol-Myers Squibb Co. rose$. 13 or. 3 percent, to $49.81. Hospira rose$. 76 or 1.4 percent, to $55.78.

  • Final Glance: Pharmaceuticals companies Friday, 15 Aug 2014 | 6:16 PM ET

    Baxter International Inc. fell$. 34 or. 5 percent, to $74.41. Bristol-Myers Squibb Co. fell$. 14 or. 3 percent, to $49.68. Hospira fell$. 69 or 1.2 percent, to $55.02.

  • Midday Glance: Pharmaceuticals companies Friday, 15 Aug 2014 | 1:15 PM ET

    Baxter International Inc. fell$. 54 or. 7 percent, to $74.21. Bristol-Myers Squibb Co. fell$. 33 or. 7 percent, to $49.49. Hospira fell$. 90 or 1.6 percent, to $54.81.

  • SAN FRANCISCO, Aug 14- A group of ex-gaming industry executives say they can use their design chops to solve a major health challenge: Sick patients neglecting to take their medication and costing employers and insurance providers billions of dollars.

  • Aug 14- An Indianapolis church has alleged that JPMorgan Chase& Co mismanaged trust accounts held for its benefit by investing in high cost, risky investments that advanced the firms' interests over its own, according to a lawsuit filed in Indianapolis federal court late on Wednesday.

  • Early Glance: Pharmaceuticals companies Thursday, 14 Aug 2014 | 10:33 AM ET

    Baxter International Inc. fell$. 23 or. 3 percent, to $74.73. Bristol-Myers Squibb Co. rose$. 60 or 1.2 percent, to $49.77. Hospira fell$. 07 or. 1 percent, to $55.09.

  • Final Glance: Pharmaceuticals companies Wednesday, 13 Aug 2014 | 6:14 PM ET

    Baxter International Inc. rose$. 69 or. 9 percent, to $74.96. Bristol-Myers Squibb Co. rose$. 19 or. 4 percent, to $49.17. Hospira rose$. 62 or 1.1 percent, to $55.16.

  • Midday Glance: Pharmaceuticals companies Wednesday, 13 Aug 2014 | 1:50 PM ET

    Baxter International Inc. rose$. 61 or. 8 percent, to $74.88. Bristol-Myers Squibb Co. rose$. 39 or. 8 percent, to $49.37. Hospira rose$. 48 or. 9 percent, to $55.02.

  • Early Glance: Pharmaceuticals companies Tuesday, 12 Aug 2014 | 12:14 PM ET

    Baxter International Inc. fell$. 16 or. 2 percent, to $74.04. Bristol-Myers Squibb Co. fell$. 01 or percent, to $49.09. Pfizer fell$. 01 or percent, to $28.24.